FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

372520005: Azelastine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1197813016 Azelastine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1211054014 Azelastine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
52861000195118 azelastina it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
793011000172117 azélastine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
67731000195110 Azelastin de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Azelastine (substance) Is a Phthalazinone derivative true Inferred relationship Some
Azelastine (substance) Is a Non-sedating antihistamine false Inferred relationship Some
Azelastine (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Histamine H1 receptor antagonist (disposition) true Inferred relationship Some
Azelastine (substance) Is a Histamine H1 receptor antagonist true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Azelastine hydrochloride Is a False Azelastine (substance) Inferred relationship Some
Product containing azelastine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azelastine (substance) Inferred relationship Some 1
Azelastine adverse reaction (disorder) Causative agent (attribute) True Azelastine (substance) Inferred relationship Some 1
Allergy to azelastine Causative agent (attribute) False Azelastine (substance) Inferred relationship Some
Product containing azelastine in ophthalmic dosage form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Azelastine (substance) Inferred relationship Some
Azelastine-containing product in nasal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azelastine (substance) Inferred relationship Some 1
Allergy to azelastine Causative agent (attribute) True Azelastine (substance) Inferred relationship Some 1
Azelastine hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Azelastine (substance) Inferred relationship Some
Product containing azelastine in ocular dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azelastine (substance) Inferred relationship Some 1
Product containing only azelastine (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azelastine (substance) Inferred relationship Some 1
Azelastine only product in nasal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azelastine (substance) Inferred relationship Some 1
Product containing only azelastine in ocular dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azelastine (substance) Inferred relationship Some 1
Product containing azelastine and fluticasone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azelastine (substance) Inferred relationship Some 1
Azelastine and fluticasone only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azelastine (substance) Inferred relationship Some 1
Azelastine and fluticasone only product in nasal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azelastine (substance) Inferred relationship Some 1
Azelastine- and fluticasone-containing product in nasal dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Azelastine (substance) Inferred relationship Some 1

Reference Sets

GB English

US English

Back to Start